A Study of Motexafin Gadolinium and Temozolomide for the Treatment of Malignant Gliomas - Related Studies

A Study of Motexafin Gadolinium and Temozolomide for the Treatment of Malignant Gliomas

This study is ongoing, but not recruiting participants.

Study NCT00080054. Last updated on January 30, 2007. Information provided by Pharmacyclics

Find Related Studies by Searching for the Conditions, Interventions, and Sponsors found in this study:


1	Conditions listed in this trial
		Glioma
		Glioblastoma
		Astrocytoma
		Oligodendroglioma
		Brain Neoplasm

2	Additional conditions recognized in this trial
		Brain Neoplasms
		Neoplasms

3	More general conditions related to this trial
		Brain Diseases
		Central Nervous System Diseases
		Central Nervous System Neoplasms
		Neoplasms by Histologic Type
		Neoplasms by Site
		Neoplasms, Germ Cell and Embryonal
		Neoplasms, Glandular and Epithelial
		Neoplasms, Nerve Tissue
		Neoplasms, Neuroepithelial
		Nervous System Diseases
		Nervous System Neoplasms
		Neuroectodermal Tumors

4	Interventions listed in this trial
		Motexafin Gadolinium Injection

5	Additional drug interventions recognized in this trial
		Motexafin gadolinium
		Temozolomide

6	More general drug interventions related to this trial
		Alkylating Agents
		Antineoplastic Agents
		Antineoplastic Agents, Alkylating
		Dermatologic Agents
		Molecular Mechanisms of Pharmacological Action
		Pharmacologic Actions
		Photosensitizing Agents
		Physiological Effects of Drugs
		Radiation-Sensitizing Agents
		Therapeutic Uses

7	Sponsors listed in this trial
		Pharmacyclics